866-997-4948(US-Canada Toll Free)

Radiology Oncology Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2016 to 2022

Published By :

Winter Green Research

Published Date : Jan 2016

Category :


No. of Pages : 557 Pages

The 2016 study has 557 pages, 82 tables and figures. Worldwide Radiology Oncology surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and use radiology for cancer surgery. New systems pinpoint the delivery of radiation precisely, eliminating the radiological overdosing that has been such a problem previously, limiting the quantity of radiation that can be delivered.
Radiosurgery robots take cancer surgery far beyond what has been available, promising a cure for cancer. Radiology oncology surgical robots use mechanical mobility and continuous image guidance to remove tumors. The Accuray CyberKnife® robotic system follows the oncology target throughout treatment, intelligently delivering sub-millimeter precision, sparing healthy tissue. A robotic manipulator and a compact, lightweight linear accelerator, can deliver beams from thousands of non-coplanar, isocentric or non-isocentric angles. Treatments have excellent tumor coverage, steep dose gradients, and tight dose conformality.
The radiation oncology market is growing globally due to a number of factors centered around the aging of the population and the benefits accrued from new technology. The number of new cancer cases diagnosed annually is projected to increase from 14.9 million in 2015 to 20 million by 2025. The increase in new cases is due to a steadily aging population. Both developed and developing countries have aging populations.
Technology advances improve the precision and applicability of radiotherapy and radiosurgery. Expanding uses of radiotherapy and radiosurgery equipment occur because the units are able to treat a broader range of cases. Advances in hardware and software are creating a market for replacing an aging installed base. New designs are able to deliver higher standards of care.
The rise in cancer cases, together with the increase in sophistication of new treatment protocols, have created demand for more automated products. Automation depends on integration of several devices into clinically practical systems. Integrated systems make treatments rapid and cost effective.
Technology advances lead to improvements in patient care. The availability of advanced, automated and efficient clinical tools in radiation therapy has brought more precise forms of radiotherapy treatment (IMRT, IGRT, VMAT, SRS, SBRT, brachytherapy and proton therapy). Technology includes the EDGE™ and Truebeam™, and the Accuray TomoTherapy H Series and CyberKnife M6 platforms that enable treatments that reduce treatment times and increase patient throughput .
International markets are under-equipped to address the growing cancer incidence. Patients in many foreign countries must frequently endure long waits for radiotherapy.
9,000 additional treatment machines will be required by 2020 in developing countries. China, India and Brazil are estimated to require over 3,800, 1,200 and 400 additional machines. Demand in emerging markets, coupled with ever increasing incidences of cancer, represent additional drivers for continued growth.
Radiology oncology surgical robot market driving forces relate to an opportunity to achieve change in medical practice regarding the treatment of cancer. Change would lead to utilization of stereotactic body radiosurgery more regularly as an alternative to surgery or other treatments. Radiosurgery is poised to revolutionize the treatment of cancer by eradicating tumors while not harming surrounding healthy tissue.
The ability to use high doses of radiation to precisely eliminate a tumor while leaving healthy tissue unharmed is compelling. It means that high doses of radiation can be delivered without killing the person, that doses of radiation delivered can be enough to kill the cancer without killing the person, this represents a change in what has been possible previously.
The Varian, Elekta, and Accuray radiology oncology surgical devices offer robust clinical treatment capabilities. Flexibility of the Accuray InCise™ Multileaf Collimator and robotic delivery permit treatment of tumors previously thought untreatable. With radiosurgery and SBRT cancer can be treated efficiently and effectively. The device offers accuracy.
“Existing open brain and abdominal cancer surgery can be replaced in large part during the forecast period by robotic radiological oncology surgery. Radiologic robotic surgical approaches complement existing open surgery techniques, but will replace them as more physicians and surgeons become skilled in manipulating the x-ray devices. Soon, all oncology surgery will be considered in the context of what part of the oncology procedure will be undertaken with at least some aspects of robotic radiologic surgery replacing or complementing open cancer surgery.
The aging US population has supported demand for robotic Radiology Oncology surgery. Since the occurrence of health issues that require medical devices is higher in the elderly population the more astute baby boomers have been looking to understand what surgical alternatives are open to them. . Buoyed by strong demand and sales, industry profit margins have increased considerably during the past five years.
Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hundreds of universities worldwide have research programs in robotics and many are awarding degrees in robotics. These “roboticists” are increasingly being hired by Global 2000 organizations to link mobile robots (mobile computers) into existing IT systems.
Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site. Surgeons no longer have to stand throughout the surgery and do not tire as quickly. Hand tremors are filtered out by the robot’s computer software. The surgical robot can continuously be used by rotating surgery teams.
Radiology Oncology surgical robot device markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 as next generation devices, systems, and instruments are introduced to manage cancer surgery through radiation excision that eliminates open cutting in the body. Patients tolerate the surgery well, walking out of the hospital after the procedure no longer bothered by healing or infection from an incision.
The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success, challenges, and strategies in each segment and sub-segment. The reports cover markets for Radiology Oncology robotic surgery medical specialties and sub-specialties.
Companies Profiled

  • Market Leaders
  • Varian
  • Elekta
  • Accuray

Market Participants

  • Best Theratronics, Ltd
  • Brainlab AG
  • Mitsubishi Heavy Industries
  • ViewRay 

Table of Contents

Radiology Oncology Surgical Robot Executive Summary 20
Radiology Oncology Surgical Robot Market Driving Forces 20
Surgical Radiology Robotics Market Driving Forces 23
Radiology Surgical Robot Key Procedures As Elements Of Strategy 27
Radiosurgery As Stereotactic Radiotherapy 28
Radiology Oncology Surgical Robots Market Share Analysis 29
Radiology Surgical Robots Market Forecasts 31

1. Radiology Surgical Robot Market Description and Market Dynamics 35
1.1 Radiotherapy, Radiation Therapy, Radiosurgery, And Brachytherapy Market Description 35
1.1.1 IMRT 36
1.1.2 VMAT 37
1.1.3 IGRT 37
1.1.4 SRS and SBRT 38
1.1.5 Brachytherapy 38
1.1.6 Proton Therapy 39
1.2 Current Radiation Therapy Limitations 40
1.3 Radiology Robotic Surgical Clinical Facilities and Clinical Diagnosis 42
1.3.1 Cancer Robotic Surgery Learning Curves 44
1.3.2 Robotic Radiological Surgery Equipment 44
1.3.3 Medicare and Medicaid Impact 46
1.3.4 Medical Robotic Surgery by Segment 46
1.3.5 Robotic Cancer Surgery 46
1.3.6 Cancer 47
1.4 Brain Tumors 48
1.4.1 Causes of Brain Tumor 49
1.4.2 Tumor Grading 49
1.4.3 Types of Treatment 50
1.4.4 Biopsies 51
1.4.5 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products 51
2D X-Ray Systems Market Driving Forces 53

2. Radiology Oncology Surgical Robot Market Shares and Market Forecasts 55
2.1 Radiology Oncology Surgical Robot Market Driving Forces 55
2.1.1 Surgical Radiology Robotics Market Driving Forces 58
2.1.2 Radiology Surgical Robot Key Procedures As Elements Of Strategy 62
2.1.3 Radiosurgery Is Stereotactic Radiotherapy 63
2.2 Radiology Oncology Surgical Robots Market Share Analysis 64
2.2.1 Accuray 67
2.2.2 Accuray Clinical Studies 68
2.2.3 Accuray Goal 69
2.2.4 Accuray Revenue 71
2.2.5 Varian 75
2.2.6 Elekta 77
2.2.7 Brainlab 80
2.2.8 Radiology Surgical Robots Market Unit Analysis 81
2.3 Radiology Surgical Robots Market Forecasts 82
2.3.1 Advanced Surgical Robotic Radiation Therapy Systems 86
2.3.2 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products 87
2.4 Cancer Incidence and Radiology Surgery Number of Procedures 88
2.5 Radiology Surgical Robots Regional Analysis 93
2.5.1 US Radiation Oncology Market 94
2.5.2 European Radiation Oncology Market 95
2.5.3 Asia Pacific Market Radiation Oncology Market 95
2.5.4 Accuray in China 96
2.5.5 Advantages of the Accuray Cyberknife treatment in China 99
2.5.6 GE Moves X-Ray Base to China to Tap Growth 100
2.5.7 Japanese Regulatory Approval for Accuray CyberKnife Robotic Full-body Radiosurgery System 101
2.5.8 Japan X-ray Systems Market 101
2.5.9 Philips Expands Global Reach Of X-Ray Solutions 101
2.5.10 Reimbursement Challenges 103

3. Radiology Surgical Robots Product Descriptions 105
3.1 Accuray CyberKnife M6 Series 105
3.1.1 Accuray CyberKnife M6 FIM System 111
3.1.2 Accuray CyberKnife® M6™ System 115
3.1.3 Accuray / CyberKnife VSI System 117
3.1.4 Accuray / TomoTherapy System 120
3.1.5 Accuray Clinical Studies 124
3.1.6 Accuray TomoTherapy® System Clinical Studies 126
3.1.7 Accuray CyberKnife® System Clinical Study 126
3.1.8 Accuray TomoTherapy System Clinical Study 126
3.1.9 Class A User Licenses for Accuray Products Awarded to 16 Hospitals in China 127
3.1.10 Accuray “Open Systems” Software Benefits 128
3.2 Elekta 129
3.2.1 Elekta Gamma Knife® Surgery 132
3.3 Varian 137
3.3.1 Varian Image Guided Radiation Therapy, Cone-Beam CT (CBCT 140
3.3.2 Varian Trilogy 140
3.3.3 Varian Edge™ Radiosurgery Suite 142
3.3.4 Varian Oncology Systems 144
3.4 ViewRay 147

4. Radiology Surgical Robots Technology and Research151
4.1 Accuray Radiology to Treat Head Cancer And Spinal Cancer 151
4.1.1 Fiducial Markers Implantation 151
4.1.2 Molding Of A Plastic Body Cradle 151
4.1.3 Treatment Planning 152
4.1.4 Programming of the Accuray Cyberknife System 152
4.1.5 Treatment Procedure 152
4.1.6 Postoperative Supervision 153
4.2 Varian Medical TrueBeam® Systems Advanced Platform 153
4.2.1 Potential of High Definition Radiotherapy 154
4.3 C-Arm Surgical X-Rays 156
4.4 X-Ray Digital Workflow 157
4.5 Stereotactic Radiosurgery 160
4.5.1 Image-Guided Stereotactic Radiosurgery 160
4.5.2 Image-Guided Stereotactic Radiosurgery Safety 160
4.6 Siemens Ysio Max (Advances in X-Ray) 161
4.7 MD Anderson Gamma Knife Radiosurgery 162
4.7.1 MD Anderson Proton Therapy Center 163
4.8 Partners Healthcare Massachusetts General Hospital Radiation Cancer Treatment 164
4.8.1 Partners Healthcare / Dana Farber 164
4.8.2 Three-Dimensional Conformal Radiation Therapy (3D-CRT) 165
4.8.3 Image Guided Radiation Therapy (IGRT) 166
4.8.4 Intensity Modulated Radiation Therapy (IMRT) 166
4.8.5 RapidArc™ Volumetric Modulated Radiotherapy 166
4.8.6 Total Body Irradiation (TBI) 167
4.8.7 Accelerated Whole Breast Radiation Therapy 167
4.8.8 Stereotactic Radiosurgery (SRS) 167
4.8.9 High Dose Rate (HDR) Brachytherapy 168
4.8.10 Robotic Transrectal Ultrasound (TRUS) Guided Radiation Therapy 168
4.9 Memorial Sloan Kettering Radiation Cancer Treatment 169
4.9.1 Memorial Sloan Kettering IMRT & IGRT 169
4.9.2 Memorial Sloan Kettering Stereotactic Radiation Therapy 170
4.9.3 Memorial Sloan Kettering Whole-Brain Radiation Therapy Stereotactic Radiosurgery, SRS 171
4.10 U.S. Regulations 172
4.10.1 Foreign Regulations 173

5. Radiology Surgical Robots Company Descriptions 175
5.1 Accuray 175
5.1.1 Accuray Revenue for Second Quarter of Fiscal Year 2015 176
5.1.2 Accuray Revenue Three Months Ended September 30, 2015 177
5.1.3 Accuray Revenue 183
5.1.4 Accuray Non-Invasively Delivers High Doses Of Radiation To Tumors With Extreme Accuracy And Intense Precision 186
5.1.5 Accuray Products 187
5.1.6 Accuray CyberKnife System 187
5.1.7 Accuray Strategy 189
5.1.8 Accuray International Presence 192
5.1.9 Accuray Competition 193
5.1.10 New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 195
5.1.11 Accuray Recall in 2013 196
5.2 Best Theratronics, Ltd 197
5.3 Brainlab AG 200
5.3.1 Brainlab AG Revenue 202
5.3.2 Brainlab 203
5.4 Elekta 204
5.4.1 Elekta Gamma Radio Surgery System 205
5.4.2 Elekta - Interim report May – October 2015/16 206
5.4.3 Elekta Transformation program on track 207
5.5 Mitsubishi Heavy Industries 210
5.5.1 Mitsubishi Heavy Industries Vero Sterotactic Body Radiotherapy 210
5.6 Varian Medical Systems 212
5.6.1 Varian Oncology Systems Business Segment 212
5.6.2 Varian Revenue 213
5.7 ViewRay 216
5.8 Accuray Locations 220
5.9 2D X-ray Equipment Leading Vendors 546

List of Table

Table ES-1 Innovative Radiology Surgical Robot Features 23 
Table ES-2 Surgical Robotics Market Driving Forces 24 
Table ES-3 Radiology Surgical Robot Market Positioning 25 
Table ES-4 Accuray CyberKnife M6 Series Systems Adoption Trends 26
Table ES-5 Radiological Surgical Robot Medical Sub-Specialties 28 
Figure ES-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015 30
Figure ES-7 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021 34
Table 1-1 Current Radiation Therapy Process and Limitations 40 
Table 1-2 Advanced Clinical Decision Support 43 
Table 1-3 Radiological Surgical Robots Benefits 45 
Figure 1-4 X-ray Diagnosing and Tracking Cancer 47 
Table 1-5 Factors That May Increase The Risk Of Complications With Radiology Cancer Surgery 48
Table 1-6 X-Ray Equipment Market Driving Forces 53 
Table 2-1 Innovative Radiology Surgical Robot Features 58 
Table 2-2 Surgical Robotics Market Driving Forces 59 
Table 2-3 Radiology Surgical Robot Market Positioning 60 
Table 2-4 Accuray CyberKnife M6 Series Systems Adoption Trends 61
Table 2-5 Radiological Surgical Robot Medical Sub-Specialties 63 
Figure 2-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015 65
Table 2-7 Radiology Surgical Linear Accelerator Market Shares, Dollars, Worldwide, 2015 66
Figure 2-8 Accuray Patient Station 70 
Table 2-9 Accuray CyberKnife Features 71 
Table 2-10 Accuray Regional Revenue Shifts 72 
Table 2-11 Elekta Gamma Knife Benefits 77 
Table 2-12 Elekta Gamma Knife® Positioning 78 
Table 2-13 Elekta Gamma Knife Perfexion Treatment Benefits 79 
Table 2-14 Elekta Gamma Knife Features 80 
Table 2-15 Radiology Surgical Linear Accelerator, Market Shares, Units and Dollars, Worldwide, 2015 81
Figure 2-16 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2016-2022 85
Table 2-17 Radiology Surgical Robot Market Segment Forecasts, Dollars and Units, Worldwide, 2016-2022 86
Table 2-18 New Cancer Cases in US, 2015, 1,658 Thousand 89
Figure 2-19 Cancer Incidence and Mortality, Worldwide 90 
Table 2-20 Accuray Surgical Robotic Advantages 91 
Figure 2-21 Radiology Surgical Robots Regional Analysis 93 
Table 2-22 Radiology Surgical Robots Market Segments 94 
Table 2-23 Accuray Regional Revenue Shifts 96 
Table 2-24 Accuray Cyberknife Radiosurgery System Treats The Following Diseases In China: 98
Table 2-25 Advantages of the Cyberknife Treatment in China 99
Table 3-1 Accuray CyberKnife M6 Series Benefits: 105 
Table 3-2 Accuray CyberKnife M6 Series Functions 106 
Table 3-3 Accuray CyberKnife M6 Series Uses 107 
Table 3-4 Accuray CyberKnife M6 Series Features 108 
Table 3-5 Accuray CyberKnife M6 Patient Comfort Features 109 
Figure 3-6 Accuray Radiology Surgical Robot 110 
Figure 3-7 Accuray CyberKnife M6 FIM System 111 
Table 3-8 Accuray CyberKnife M6 FIM System Features 112 
Figure 3-9 Accuray CyberKnife M6 FM System 113 
Table 3-10 Accuray CyberKnife M6 FM System Design Features 114
Figure 3-11 Accuray CyberKnife M6 FI System 115 
Figure 3-12 Accuray / CyberKnife VSI System 117 
Table 3-13 Accuray CyberKnife VSI™ Radiosurgery System Functions 118 
Table 3-14 Accuray CyberKnife VSI™ Radiosurgery System Treatment Options 119
Figure 3-15 Accuray TomoTherapy® System 120 
Table 3-16 Accuray TomoTherapy System Benefits 121 
Table 3-17 Accuray Cancer Conditions Treated via Surgical Robot 123
Table 3-18 Accuray Open Systems Software Benefits 128 
Table 3-19 Accuray Open Systems Software Challenges 129 
Figure 3-20 Human Brain with Cancer Tumors 130 
Figure 3-21 Elekta Lexsell Gamma Knife® PERFEXIONTM System 131 
Table 3-22 Conditions for Elekta Gamma Knife® Efficacy 134 
Table 3-23 Advantages of Elekta Gamma Knife® 135 
Figure 3-24 Elekta Market Leading Solutions Portfolio 136 
Figure 3-25 Varian Radiosurgery System 137 
Figure 3-26 Varian Radiation Surgery Capabilities 139 
Figure 3-27 Varian Trilogy 141 
Table 3-28 Varian Oncology Product Set 145 
Table 3-28 146 Varian Oncology Product Set 146 
Figure 3-29 ViewRay On-Table Dose Prediction And Re-Optimization 147 
Figure 3-30 ViewRay MRIdian® System 149 
Table 3-31 ViewRay MRIdian® System Functions 150 
Figure 4-1 X-Ray Digital Workflow 157 
Figure 4-2 Digital X-Ray Equ9pm3n35 Part of Paperless Workflow in Hospital 158
Figure 4-3 Departmental Picture Archiving And Communication System PACS: Clinical Productivity 159
Table 4-4 Elekta Gamma Knife Surgery Targets 162 Accuray Regional Revenue Shifts 176
Table 5-1 Accuray Strategy 190 
Table 5-2 Accuray Key Elements Of Strategy 191 
Table 5-3 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator Features 198
Figure 5-4 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator 199
Figure 5-5 Brainlab Collaborative Workspace 200 
Figure 5-6 Brainlab AG Worldwide Presence, Headquarters in Germany 201
Figure 5-7 Elekta Gamma Radio Surgery System 205 
Figure 5-8 Mitsubishi Heavy Industries Vero RadioTherapy 211 
Table 5-9 ViewRay Early Adopters: 218

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *